Literature DB >> 30226992

When Do Patients Improve After Hip Arthroscopy for Femoroacetabular Impingement? A Prospective Cohort Analysis.

Sergio E Flores1, Joseph R Sheridan1, Kristina R Borak1, Alan L Zhang1.   

Abstract

BACKGROUND: Hip arthroscopy for femoroacetabular impingement (FAI) has been shown to improve patient outcomes, especially for returning to sport. Although previous studies often evaluated outcomes 2 years after hip arthroscopy, there has been no analysis of the progression of patient improvement over time or with respect to achieving the minimal clinically important difference (MCID). HYPOTHESIS/
PURPOSE: The purpose was to prospectively evaluate changes in patient-reported outcome (PRO) scores during the first 2 years after hip arthroscopy for FAI and to analyze when the MCID is achieved. It was hypothesized that clinically significant changes will be reached by 1 year after surgery. STUDY
DESIGN: Case series; Level of evidence, 4.
METHODS: Patients undergoing hip arthroscopy for FAI were prospectively enrolled, and they completed the 12-Item Short Form Health survey (SF-12), modified Harris Hip Score, and Hip disability and Osteoarthritis Outcome Score (HOOS) at preoperative baseline and 3 months, 6 months, 1 year, and 2 years after surgery. Mean scores and the percentage of patients reaching the MCID at each time point were analyzed via analysis of variance and Cochrane-Armitage trend tests.
RESULTS: A total of 129 hips from 122 patients were evaluated, revealing significant improvements after hip arthroscopy for FAI (PRO scores increased 19 to 45 points) with 95.8%, 93.6%, and 84.8% of patients achieving the MCID for HOOS-Sports, HOOS-Quality of Life (QoL), and HOOS-Pain, respectively, at 2-year follow-up. Analysis of PRO change showed that for all scores, the greatest improvement occurred from presurgery to postoperative 3 months, with lesser improvements at subsequent 6-month, 1-year, and 2-year time points ( P < .001). The SF-12 physical component score, HOOS-Sports, and HOOS-QoL continued to show statistically significant improvements through 2 years, while other scores plateaued after 3 months. The percentage of patients achieving the MCID for HOOS-Sports, HOOS-QoL, and HOOS-Pain continued to increase over 2 years, but the percentage achieving the MCID did not increase after 3 months for all other scores.
CONCLUSION: Hip arthroscopy for FAI yields significant improvements in patient outcomes within 2 years of surgery. The majority of improvement occurs within 3 months after surgery, but certain outcomes, such as returning to sport, QoL, and pain, can continue to improve through 2 years.

Entities:  

Keywords:  femoroacetabular impingement (FAI); hip arthroscopy; minimal clinically important difference (MCID); patient outcomes; rate of improvement

Mesh:

Year:  2018        PMID: 30226992     DOI: 10.1177/0363546518795696

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  22 in total

1.  Prediction of intra-articular pathology and arthroscopic outcomes for femoroacetabular impingement and labral tear based on the response to preoperative anaesthetic hip joint injections.

Authors:  Mingjin Zhong; Kan Ouyang; Weimin Zhu
Journal:  Eur J Orthop Surg Traumatol       Date:  2020-09-12

2.  Preoperative Psychosocial Factors and Short-term Pain and Functional Recovery After Hip Arthroscopy for Femoroacetabular Impingement Syndrome.

Authors:  Kate N Jochimsen; Brian Noehren; Carl G Mattacola; Stephanie Di Stasi; Stephen T Duncan; Cale Jacobs
Journal:  J Athl Train       Date:  2021-10-01       Impact factor: 3.824

3.  Is There a Gender Gap in Outcomes After Hip Arthroscopy for Femoroacetabular Impingement? Assessment of Clinically Meaningful Improvements in a Prospective Cohort.

Authors:  Sergio E Flores; Caitlin C Chambers; Kristina R Borak; Alan L Zhang
Journal:  Orthop J Sports Med       Date:  2020-07-14

4.  A comparison of 6-month outcomes between periacetabular osteotomy with concomitant hip arthroscopy to isolated hip arthroscopy for femoroacetabular impingement.

Authors:  Thomas Ellis; Dave Kohlrieser; Brian Rao; Keelan Enseki; Adam Popchak; RobRoy L Martin
Journal:  Arch Orthop Trauma Surg       Date:  2021-04-18       Impact factor: 3.067

Review 5.  Reporting Clinical Significance in Hip Arthroscopy: Where Are We Now?

Authors:  Breanna A Polascik; Jeffrey Peck; Nicholas Cepeda; Stephen Lyman; Daphne Ling
Journal:  HSS J       Date:  2020-04-12

6.  Changes in Hip Capsule Morphology after Arthroscopic Treatment for Femoroacetabular Impingement Syndrome with Periportal Capsulotomy are Correlated With Improvements in Patient-Reported Outcomes.

Authors:  Kevin H Nguyen; Chace Shaw; Thomas M Link; Sharmila Majumdar; Richard B Souza; Thomas P Vail; Alan L Zhang
Journal:  Arthroscopy       Date:  2021-05-28       Impact factor: 4.772

7.  Outcomes of Hip Arthroscopy for Femoroacetabular Impingement in Chinese Patients Aged 50 Years or Older.

Authors:  Feng Gao; Baiqing Zhang; Bo Hu; Ming Lu; Mingyang An; Yufeng Liu; Yehan Fang; Gang Zhao; Chao Shi; Jingbin Zhou; Yujie Liu; Chunbao Li
Journal:  Orthop Surg       Date:  2020-05-27       Impact factor: 2.071

8.  Short term outcomes of hip arthroscopy on hip joint mechanics and cartilage health in patients with femoroacetabular impingement syndrome.

Authors:  Michael A Samaan; Trevor Grace; Alan L Zhang; Sharmila Majumdar; Richard B Souza
Journal:  Clin Biomech (Bristol, Avon)       Date:  2019-11-26       Impact factor: 2.063

9.  Five-Year Outcomes After Arthroscopic Surgery for Femoroacetabular Impingement Syndrome in Elite Athletes.

Authors:  Ida Lindman; Axel Öhlin; Neel Desai; Kristian Samuelsson; Olufemi R Ayeni; Eric Hamrin Senorski; Mikael Sansone
Journal:  Am J Sports Med       Date:  2020-03-20       Impact factor: 6.202

10.  Return to Duty After Mini-Open Arthroscopic-Assisted Treatment of Femoroacetabular Impingement in an Active Military Population.

Authors:  Justin J Ernat; Daniel J Song; J Matthew Cage; Gregory Y Lee; John M Tokish
Journal:  Arthrosc Sports Med Rehabil       Date:  2019-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.